Monitoring amiodarone therapy, especially when amiodarone is coadministered with other drugs that may interact Evaluating possible amiodarone toxicity
Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are
intravenous amiodarone to oral amiodarone (see DOSAGE dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
OF AMIODARONE THERAPY CORRELATES. STRONGLY WITH ACCUMULATION OF SERUM achieved during the first year of amiodarone therapy (Panel A). [AM] was
Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are
INTRAVENOUS AMIODARONE EFFECTIVE AS EMERGENCY THERAPY. Oral amiodarone has recently emerged as an important therapy for malignant ventricular
Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are
Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are
Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are
Comments